Tagged articles

8 articles

Page 1 of 1

May 2, 2026 · Artificial Intelligence

Joint Modeling Predicts New Drugs in Nature: AI Maps a Billion‑Molecule Chemical Frontier

The article presents a joint molecular model that combines property prediction with molecule reconstruction, introduces a "strangeness" metric to detect distribution shift, validates it on 33 datasets, applies it to a 140k virtual screen, and experimentally discovers seven highly novel kinase inhibitors.

AI drug discoverydistribution shiftjoint molecular model

0 likes · 7 min read

Joint Modeling Predicts New Drugs in Nature: AI Maps a Billion‑Molecule Chemical Frontier

AI Explorer

Mar 30, 2026 · Industry Insights

Lilly’s $2.75 B Bet on AI Drug Discovery: A Potential Turning Point for Pharma R&D

Lilly’s recent RMB 2.75 billion investment in AI-driven drug discovery firm Insilico Medicine signals a strategic shift from using AI as a supplementary tool to a core engine, highlighting both the promise of accelerated target identification and the lingering challenges of clinical validation, data quality, and regulatory acceptance.

AI drug discoveryInsilico MedicineLilly investment

0 likes · 5 min read

Lilly’s $2.75 B Bet on AI Drug Discovery: A Potential Turning Point for Pharma R&D

AI Explorer

Mar 30, 2026 · Industry Insights

AI Tech Daily March 30 2026: PaddleOCR tops GitHub, New Large Models, and Security Advances

The March 30, 2026 AI Tech Daily highlights PaddleOCR surpassing Tesseract with 73.3K stars, GigaWorld's GigaBrain models leading global rankings, Eli Lilly's 2.75 billion‑RMB AI drug‑discovery investment, Doubao joining top‑tier LLMs, Stanford's InfoTok video tokenization breakthrough, Claude's rapid vulnerability exploit, a new Claude model beating Opus 4.6, Node.js core members petitioning to ban AI‑assisted coding, Kimi K2.5 reaching $1 billion monthly revenue, a startup's tiny model delivering 15× inference speed, and Claude's 15 KB engine boosting rendering speed 1,200×.

AI drug discoveryClaudeGigaBrain

0 likes · 6 min read

AI Tech Daily March 30 2026: PaddleOCR tops GitHub, New Large Models, and Security Advances

Data Party THU

Jan 26, 2026 · Artificial Intelligence

How PropMolFlow Boosts Property‑Guided Molecule Generation by Tenfold

PropMolFlow, a new flow‑matching model introduced by researchers from the University of Florida and NYU, generates property‑guided molecules up to ten times faster than prior SOTA methods while preserving chemical validity and achieving superior performance on benchmarks such as QM9.

AI drug discoveryPropMolFlowcomputational chemistry

0 likes · 7 min read

How PropMolFlow Boosts Property‑Guided Molecule Generation by Tenfold

HyperAI Super Neural

Sep 26, 2025 · Artificial Intelligence

Nvidia’s ReaSyn Uses Chain‑of‑Reaction Reasoning to Boost Molecule Reconstruction and Path Diversity

ReaSyn, a new framework from Nvidia’s research team, treats synthesis pathways as chain‑of‑thought reasoning using a novel Chain‑of‑Reaction representation, achieving the highest reconstruction rates and path diversity in molecule synthesis tasks, and outperforming prior methods across multiple benchmark optimizations.

AI drug discoveryReaSynReinforcement Learning

0 likes · 14 min read

Nvidia’s ReaSyn Uses Chain‑of‑Reaction Reasoning to Boost Molecule Reconstruction and Path Diversity

Huawei Cloud Developer Alliance

Sep 25, 2024 · Artificial Intelligence

AI-Driven Drug Discovery Shines at Shanghai’s First Computational Biology Competition

The inaugural Shanghai International Computational Biology Innovation Competition concluded with five finalist teams, awarding a GeminiMol team from ShanghaiTech University first prize for discovering highly active molecules validated by wet experiments, while the event showcased AI-driven drug discovery targeting the NMDA receptor, highlighted the city’s new computational biology action plan, and emphasized talent selection through competition.

AI drug discoveryNMDA receptorShanghai competition

0 likes · 7 min read

AI-Driven Drug Discovery Shines at Shanghai’s First Computational Biology Competition

Baidu Intelligent Cloud Tech Hub

Apr 17, 2023 · Artificial Intelligence

How NVIDIA’s GPU‑Powered AI is Revolutionizing Drug Discovery and Genomics

The article outlines NVIDIA’s CLARA platform, BioNeMo framework, and GPU‑accelerated tools such as CLARA Parabricks and RAPIDS, demonstrating how AI and high‑performance computing dramatically speed up drug‑target identification, molecular generation, protein structure prediction, and high‑throughput DNA/RNA sequencing, with benchmarks showing up to 80‑fold acceleration.

AI drug discoveryBioNeMoCLARA

0 likes · 11 min read

How NVIDIA’s GPU‑Powered AI is Revolutionizing Drug Discovery and Genomics

DataFunTalk

Dec 25, 2022 · Artificial Intelligence

GraphSynergy: A Network‑Inspired Deep Learning Model for Predicting Anti‑Cancer Drug Combinations

GraphSynergy integrates network science and graph convolutional networks to predict synergistic anti‑cancer drug combinations by modeling protein‑protein interaction networks, computing therapy and toxicity scores, and outperforming baseline methods on DrugCombDB and Oncology‑Screen datasets, while offering interpretable mechanisms for drug repurposing.

AI drug discoverycancer therapydrug repurposing

0 likes · 19 min read

GraphSynergy: A Network‑Inspired Deep Learning Model for Predicting Anti‑Cancer Drug Combinations